These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18855601)
41. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel. Chen J; Qiu L; Hu M; Jin Y; Han J Drug Dev Ind Pharm; 2008 Jun; 34(6):588-94. PubMed ID: 18568908 [TBL] [Abstract][Full Text] [Related]
42. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system. Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166 [TBL] [Abstract][Full Text] [Related]
43. Effect of poloxamers on nifedipine microparticles prepared by Hot Air Coating technique. Pattarino F; Giovannelli L; Bellomi S Eur J Pharm Biopharm; 2007 Feb; 65(2):198-203. PubMed ID: 17008076 [TBL] [Abstract][Full Text] [Related]
44. Inlay osmotic pump tablets containing metformin and glipizide. Patel RB; Patel GN; Patel HR; Patel MM Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414 [TBL] [Abstract][Full Text] [Related]
45. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery. Pan H; Jing H; Yang X; Pan W; Chen T Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057 [TBL] [Abstract][Full Text] [Related]
46. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. Huang J; Wigent RJ; Schwartz JB J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668 [TBL] [Abstract][Full Text] [Related]
47. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes. Patel PJ; Gajera BY; Dave RH Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778 [TBL] [Abstract][Full Text] [Related]
48. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug. Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985 [TBL] [Abstract][Full Text] [Related]
49. Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form. Haznar-Garbacz D; Kaminska E; Zakowiecki D; Lachmann M; Kaminski K; Garbacz G; Dorożyński P; Kulinowski P AAPS PharmSciTech; 2018 Feb; 19(2):951-960. PubMed ID: 29098644 [TBL] [Abstract][Full Text] [Related]
50. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Ghebremeskel AN; Vemavarapu C; Lodaya M Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659 [TBL] [Abstract][Full Text] [Related]
51. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets. Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems. Malaterre V; Ogorka J; Loggia N; Gurny R Drug Dev Ind Pharm; 2009 Apr; 35(4):433-9. PubMed ID: 18989838 [TBL] [Abstract][Full Text] [Related]
53. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques. Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219 [TBL] [Abstract][Full Text] [Related]
54. Gastroretentive drug delivery system of Ranitidine hydrochloride based on osmotic technology: development and evaluation. Kumar P; Singh S; Mishra B Curr Drug Deliv; 2008 Oct; 5(4):332-42. PubMed ID: 18855605 [TBL] [Abstract][Full Text] [Related]
55. Development and evaluation of push-pull based osmotic delivery system for pramipexole. Wakode R; Bhanushali R; Bajaj A PDA J Pharm Sci Technol; 2008; 62(1):22-31. PubMed ID: 18402365 [TBL] [Abstract][Full Text] [Related]
56. Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination. Kumaravelrajan R; Narayanan N; Suba V Lipids Health Dis; 2011 Apr; 10():51. PubMed ID: 21477386 [TBL] [Abstract][Full Text] [Related]
57. Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. Suzuki H; Sunada H Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1688-93. PubMed ID: 9353898 [TBL] [Abstract][Full Text] [Related]
58. In vitro-in vivo evaluation of nanosuspension release from subcutaneously implantable osmotic pumps. Hill A; Geissler S; Meyring M; Hecht S; Weigandt M; Mäder K Int J Pharm; 2013 Jul; 451(1-2):57-66. PubMed ID: 23628403 [TBL] [Abstract][Full Text] [Related]
59. Characterization of poly(ethylene oxide) as a drug carrier in hot-melt extrusion. Li L; AbuBaker O; Shao ZJ Drug Dev Ind Pharm; 2006 Sep; 32(8):991-1002. PubMed ID: 16954112 [TBL] [Abstract][Full Text] [Related]
60. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design. Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]